... Breast Cancer (ABC) at the 2021 San Antonio Breast Cancer Symposium ... Celcuity is a clinical-stage biotechnology company seeking to extend ...
News
- Celcuity Presents Updated Results of Phase 1b Study of Gedatolisib in Combination with ...
- Puma Biotechnology Presents Updates from the SUMMIT Trial at the 2021 SABCS Annual Meeting
Puma Biotechnology presented an update on its Phase II SUMMIT Trial in an oral presentation at the 2021 San Antonio Breast Cancer Symposium.
- SABCS: Subgroup analysis of trastuzumab derux | EurekAlert!
... important findings at the San Antonio Breast Cancer Symposium Dec. ... Phoenix Molecular Designs, Pieris Pharmaceuticals, Puma Biotechnology, ...
- Oncolytics Biotech® Presents Positive Interim Safety Update from Phase 2 Triple-Negative ...
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) announced a ... in a poster presentation at the 2021 San Antonio Breast Cancer Symposium (SABCS).
- Biotechs Share Promising Breast Cancer Data at San Antonio Symposium | BioSpace
The 2021 San Antonio Breast Cancer Symposium is meeting December 7–10 at the Henry B. Gonzalez Convention Center in San Antonio, Texas, ...